Cargando…
Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
Neurofibromatosis type 1 (NF1) is the most common tumor predisposition disorder affecting 1/3500 worldwide. Patients are at risk of developing benign (neurofibromas) and malignant peripheral nerve sheath tumors (MPNST). The AXL receptor tyrosine kinase has been implicated in several kinds of cancers...
Autores principales: | Johansson, Gunnar, Peng, Po-Chun, Huang, Po-Yuan, Chien, Hsiung-Fei, Hua, Kuo-Tai, Kuo, Min-Liang, Chen, Chin-Tin, Lee, Ming-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281253/ https://www.ncbi.nlm.nih.gov/pubmed/25551830 http://dx.doi.org/10.1371/journal.pone.0115916 |
Ejemplares similares
-
Correction: Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
Publicado: (2015) -
A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy
por: Chen, Chin-Tin, et al.
Publicado: (2020) -
Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
por: Lin, Jen-Tai, et al.
Publicado: (2021) -
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
por: Staufer, Katharina, et al.
Publicado: (2017) -
High glucose induces human endothelial dysfunction through an Axl-dependent mechanism
por: Lee, Chien-Hsing, et al.
Publicado: (2014)